dc.contributor.author |
Sharma, Rashmi |
|
dc.contributor.author |
Pandey, A K |
|
dc.contributor.author |
Shivahare, Rahul |
|
dc.contributor.author |
Srivastava, Khushboo |
|
dc.contributor.author |
Gupta, Suman |
|
dc.contributor.author |
Chauhan, P M S |
|
dc.date.accessioned |
2014-05-19T06:36:15Z |
|
dc.date.available |
2014-05-19T06:36:15Z |
|
dc.date.issued |
2014 |
|
dc.identifier.citation |
Bioorganic Medicinal Chemistry Letters 2014, 24, 298–301 |
en |
dc.identifier.uri |
http://hdl.handle.net/123456789/1243 |
|
dc.description.abstract |
A novel series of 1,2,4-triazino-[5,6b]indole-3-thione covalently linked to 7-chloro-4-aminoquinoline have been synthesized and evaluated for their in vitro activity against extracellular promastigote and intracellular amastigote form of Leishmania donovani. Among all tested compounds, compound 7a and 7b was found to be the most active with IC50 values 1.11, 0.36 μM and selectivity index (SI) values 67, >1111 respectively against amastigote form of L. donovani which is several folds more potent than the standard drugs, miltefosine (IC50 = 8.10 µM, SI = 7) and sodium stibo-gluconate (IC50 = 54.60 µM, SI = >7). |
en |
dc.format.extent |
136333 bytes |
|
dc.format.mimetype |
application/pdf |
|
dc.language.iso |
en |
en |
dc.relation.ispartofseries |
CSIR-CDRI communication no. 8565 |
en |
dc.subject |
Antileishmanial |
en |
dc.subject |
Hybrid |
en |
dc.subject |
In vitro |
en |
dc.subject |
Leishmania donovani |
en |
dc.subject |
Quinoline |
en |
dc.subject |
Triazino-indole |
en |
dc.title |
Triazino indole-Quinoline hybrid: A novel approach to Antileishmanial agents |
en |
dc.type |
Article |
en |